Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial

Documenti analoghi

• Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
  di: Truman, Lucy A, et al.
  Pubblicazione: (2015)
• Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
  di: Todd, John A., et al.
  Pubblicazione: (2016)
• Genogroup IV and VI Canine Noroviruses Interact with Histo-Blood Group Antigens
  di: Caddy, Sarah, et al.
  Pubblicazione: (2014)
• IL-21 production by CD4(+) effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients
  di: Ferreira, Ricardo C., et al.
  Pubblicazione: (2015)
• Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2
  di: Pekalski, Marcin L., et al.
  Pubblicazione: (2017)